Covid cases set to hit new record as experts call for return of free testing

Brasil Notícia Notícia

Covid cases set to hit new record as experts call for return of free testing
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 i newspaper
  • ⏱ Reading Time:
  • 54 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 89%

🔴 Covid cases are about to hit a new record after daily symptomatic infections reached 348,001 – just a few hundred below the previous high in March

are about to hit a new record after daily symptomatic infections reached 348,001 – just a few hundred below the previous high in March.

They recommend a wide range of measures, from encouraging the public to keep windows open to calling on the Government to invest in air filtration systems in schools. “We clearly need a long-term strategy. It is unsustainable to live with three waves occurring within 6 months, leading to significant impact in terms of long Covid, pressures on the NHS, deaths, and societal disruption.”

“But to stop this cycle happening over and over again, so that we can sustainably live with the Covid, we need the Government to do much more: bring back free testing for people, increase sick pay and encourage those with Covid or symptoms of Covid to stay home. “Leaving vaccines to deal with the pandemic alone simply isn’t working and we need to do more over the longer term to build resilience against such a high level of infections.

“The Government has removed protections like free testing and financial self-isolation support, and little seems to have been done to fundamentally improve things which can help to reduce the impact of Covid in the long run.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

i newspaper /  🏆 8. in UK

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Omicron Booster Jabs On Horizon As Covid Cases And Hospitalisations ClimbOmicron Booster Jabs On Horizon As Covid Cases And Hospitalisations ClimbAn estimated one in 30 of us has Covid, leading to renewed calls for booster jabs from health experts.
Consulte Mais informação »

New York Cuts Back Covid Testing Amid U.S. Summer Surge in CasesNew York Cuts Back Covid Testing Amid U.S. Summer Surge in CasesNew York City is scaling back on COVID-19 testing sites despite omicron subvariants that are driving a nationwide rise in new cases and hospitalization rates
Consulte Mais informação »

E.U. Mounts Urgent Call for COVID-19 Boosters as Cases Rise AgainE.U. Mounts Urgent Call for COVID-19 Boosters as Cases Rise AgainEuropean regulators are urging second booster doses of Covid-19 vaccines for people over 60 years old as cases and hospitalizations are again rising sharply
Consulte Mais informação »

Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation - Critical CareKey characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation - Critical CareBackground Severe COVID-19 induced acute respiratory distress syndrome (ARDS) often requires extracorporeal membrane oxygenation (ECMO). Recent German health insurance data revealed low ICU survival rates. Patient characteristics and experience of the ECMO center may determine intensive care unit (ICU) survival. The current study aimed to identify factors affecting ICU survival of COVID-19 ECMO patients. Methods 673 COVID-19 ARDS ECMO patients treated in 26 centers between January 1st 2020 and March 22nd 2021 were included. Data on clinical characteristics, adjunct therapies, complications, and outcome were documented. Block wise logistic regression analysis was applied to identify variables associated with ICU-survival. Results Most patients were between 50 and 70 years of age. PaO2/FiO2 ratio prior to ECMO was 72 mmHg (IQR: 58–99). ICU survival was 31.4%. Survival was significantly lower during the 2nd wave of the COVID-19 pandemic. A subgroup of 284 (42%) patients fulfilling modified EOLIA criteria had a higher survival (38%) (p = 0.0014, OR 0.64 (CI 0.41–0.99)). Survival differed between low, intermediate, and high-volume centers with 20%, 30%, and 38%, respectively (p = 0.0024). Treatment in high volume centers resulted in an odds ratio of 0.55 (CI 0.28–1.02) compared to low volume centers. Additional factors associated with survival were younger age, shorter time between intubation and ECMO initiation, BMI | 35 (compared to | 25), absence of renal replacement therapy or major bleeding/thromboembolic events. Conclusions Structural and patient-related factors, including age, comorbidities and ECMO case volume, determined the survival of COVID-19 ECMO. These factors combined with a more liberal ECMO indication during the 2nd wave may explain the reasonably overall low survival rate. Careful selection of patients and treatment in high volume ECMO centers was associated with higher odds of ICU survival. Trial registration Registered in the German Clinical Trials Re
Consulte Mais informação »

Covid-19 vaccines saved an estimated 20m lives during their first yearCovid-19 vaccines saved an estimated 20m lives during their first yearAs bad as the past 18 months have been, they would have been worse without vaccines—perhaps about 2.7 times worse
Consulte Mais informação »



Render Time: 2025-03-06 15:42:33